Fig. 5
From: Naringin attenuates angiotensin II induced cardiac hypertrophy by inhibiting carbonic anhydrase II
Inhibition of Ang II-induced CA-II activity by nutraceuticals in H9c2 cells (# vs. control group; * vs. Ang II group; *P, 0.05, ## and **P, 0.01, ### and ***P, 0.001). Data represents mean ± SEM (n = 3).
